Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
51 studies found for:    "Epidermolysis Bullosa" OR "epidermolysis bullosa with pyloric atresia"
Show Display Options
Rank Status Study
21 Not yet recruiting Diacerin for the Treatment of Epidermolysis Bullosa Simplex
Condition: Epidermolysis Bullosa Simplex
Intervention: Drug: Diacerin cream
22 Completed Treatment of Epidermolysis Bullosa Dystrophica by Polyphenon E (Epigallocatechin 3 Gallate)
Condition: Epidermolysis Bullosa Dystrophica
Interventions: Drug: Polyphenon E before Placebo;   Drug: placebo before treatment
23 Unknown  Treatment of Dowling Maera Type of Epidermolysis Bullosa Simplex by Oral Erythromycin
Condition: Epidermolysis Bullosa
Intervention: Drug: Oral erythromycin
24 Recruiting Characteristics of Patients With Recessive Dystrophic Epidermolysis Bullosa
Condition: Epidermolysis Bullosa Dystrophica
Intervention:
25 Unknown  Botulinumtoxin A Treatment in Epidermolysis Bullosa Simplex and Pachyonychia Congenita
Condition: Epidermolysis Bullosa Simplex
Interventions: Drug: Dysport® (Botulinumtoxin A (Btx A));   Drug: Placebo
26 Completed Characteristics of Adult Patients With Recessive Dystrophic Epidermolysis Bullosa
Condition: Epidermolysis Bullosa Dystrophica
Intervention:
27 Recruiting A Study of FCX-007 for Recessive Dystrophic Epidermolysis Bullosa (RDEB)
Condition: Epidermolysis Bullosa Dystrophica, Recessive
Interventions: Genetic: FCX-007;   Drug: Sterile Saline
28 Completed Efficacy of Granulocyte Colony Stimulating Factor (GCSF) In Patients With Dystrophic Epidermolysis Bullosa
Condition: Dystrophic Epidermolysis Bullosa
Intervention: Drug: Granulocyte Colony Stimulating Factor (GCSF)
29 Recruiting A Comparative Study of the Healing of Chronic Ulcers of Recessive Epidermolysis Bullosa : Dressing vs Amniotic Membrane
Conditions: Epidermolysis Bullosa Dystrophica, Recessive;   Ulcer
Intervention: Device: Amniotic Membrane
30 Withdrawn Grafting of Epidermolysis Bullosa Wounds Using Cultured Revertant Autologous Keratinocytes
Condition: Epidermolysis Bullosa
Intervention: Procedure: Grafting of Autologous Cultured Revertant Keratinocytes
31 Recruiting Mesenchymal Stromal Cells in Adults With Recessive Dystrophic Epidermolysis Bullosa
Condition: Recessive Dystrophic Epidermolysis Bullosa
Intervention: Drug: Mesenchymal stromal cells
32 Recruiting Stem Cell Transplant for Epidermolysis Bullosa
Condition: Epidermolysis Bullosa
Interventions: Drug: Cyclophosphamide;   Drug: Fludarabine;   Drug: Anti-thymocyte globulin;   Drug: Cyclosporine A;   Drug: Mycophenolate mofetil;   Procedure: Mesenchymal stem cell transplantation;   Radiation: Total body irradiation;   Procedure: Bone marrow or umbilical cord blood (UCG) stem cell transplantation
33 Recruiting Safety Study of Gene-modified Autologous Fibroblasts in Recessive Dystrophic Epidermolysis Bullosa
Condition: Recessive Dystrophic Epidermolysis Bullosa
Intervention: Drug: Gene-modified autologous fibroblasts
34 Unknown  Study of Immune Tolerance and Capacity for Wound Healing of Patients With Recessive Dystrophic Epidermolysis Bullosa (RDEB)
Condition: Recessive Dystrophic Epidermolysis Bullosa
Interventions: Other: Blood collection;   Other: Skin biopsies
35 Recruiting Topical BPM31510 3.0% Cream in Patients With Epidermolysis Bullosa
Condition: Epidermolysis Bullosa
Intervention: Drug: topical BPM31510 3.0% Cream
36 Unknown  Randomised Double Blind Crossover Placebo Controlled Study to Evaluate the Efficacy of Tetracycline in Epidermolysis Bullosa
Condition: Epidermolysis Bullosa
Intervention: Drug: tetracyclin
37 Terminated A Observational Study to Evaluate Apligraf(R) in Nonhealing Wounds of Subjects With Epidermolysis Bullosa
Conditions: Epidermolysis Bullosa;   Wound Healing
Intervention: Device: Apligraf
38 Completed Phase I Study of Isotretinoin in Patients With Recessive Dystrophic Epidermolysis Bullosa
Condition: Epidermolysis Bullosa
Intervention: Drug: isotretinoin
39 Completed Phase II Pilot Study of Extracorporeal Phototherapy for Epidermolysis Bullosa Acquisita
Condition: Epidermolysis Bullosa Acquisita
Intervention: Drug: methoxsalen
40 Completed Establishment of the National Epidermolysis Bullosa Registry
Condition: Epidermolysis Bullosa
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-51) Show next page of results    Last Page
Indicates status has not been verified in more than two years